Hyderabad Institute Of Oncology Profile
Key Indicators
- Authorised Capital ₹ 24.99 Cr
as on 16-06-2024
- Paid Up Capital ₹ 6.00 Cr
as on 16-06-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 90.70 Cr
as on 16-06-2024
- Satisfied Charges ₹ 44.81 Cr
as on 16-06-2024
- Revenue 8.40%
(FY 2023)
- Profit 0.42%
(FY 2023)
- Ebitda 1.78%
(FY 2023)
- Net Worth 7.29%
(FY 2023)
- Total Assets 83.54%
(FY 2023)
About Hyderabad Institute Of Oncology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 24.99 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹90.70 Cr. The company has closed loans amounting to ₹44.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nagavardhanamma Parvathaneni, Mohan Chigurupati, and Padmaja Chigurupati serve as directors at the Company.
- CIN/LLPIN
U85110TG2010PTC066521
- Company No.
066521
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hyderabad Institute Of Oncology?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Chigurupati  | Managing Director | 27-Mar-2010 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagavardhanamma Parvathaneni | Director | 14-Mar-2011 | Current |
| Padmaja Chigurupati | Director | 27-Mar-2010 | Current |
Financial Performance and Corporate Structure Insights of Hyderabad Institute Of Oncology.
Hyderabad Institute Of Oncology Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.4% increase. The company also saw a slight improvement in profitability, with a 0.42% increase in profit. The company's net worth moved up by a moderate rise of 7.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyderabad Institute Of Oncology?
In 2023, Hyderabad Institute Of Oncology had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Omega Century Institute Of Oncology Private LimitedActive 6 years 1 monthMohan Chigurupati is a mutual person
- Guntur Institute Of Oncology Private LimitedActive 10 years 29 days
Padmaja Chigurupati is a mutual person
Kakatiya Institute Of Oncology Private LimitedActive 6 years 10 monthsPadmaja Chigurupati is a mutual person
Zafonic Finlease And Investments Private LimitedActive 30 years 3 monthsNagavardhanamma Parvathaneni is a mutual person
- Animation Finvest Private LimitedActive 29 years 12 days
Nagavardhanamma Parvathaneni is a mutual person
- Bhimavaram Institute Of Oncology Private LimitedActive 4 years 4 months
Mohan Chigurupati is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Sep 2023 | ₹30.00 Cr | Open |
Others Creation Date: 29 Mar 2023 | ₹7.00 Cr | Open |
Others Creation Date: 29 Mar 2023 | ₹3.00 Cr | Open |
How Many Employees Work at Hyderabad Institute Of Oncology?
Hyderabad Institute Of Oncology has a workforce of 881 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyderabad Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Institute Of Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
